Neutralization of CXCL12 attenuates established pulmonary hypertension in rats
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neutralization of CXCL12 attenuates established pulmonary hypertension in rats
Authors
Keywords
-
Journal
CARDIOVASCULAR RESEARCH
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-06-04
DOI
10.1093/cvr/cvz153
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimising experimental research in respiratory diseases: an ERS statement
- (2018) Philippe Bonniaud et al. EUROPEAN RESPIRATORY JOURNAL
- Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension
- (2018) Yuichi Tamura et al. JOURNAL OF CLINICAL INVESTIGATION
- Inflammatory Macrophage Expansion in Pulmonary Hypertension Depends upon Mobilization of Blood-Borne Monocytes
- (2018) Jonathan Florentin et al. JOURNAL OF IMMUNOLOGY
- Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension
- (2018) Morane Le Hiress et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chemokine receptor 7 overexpression promotes mesenchymal stem cell migration and proliferation via secreting Chemokine ligand 12
- (2018) Ling Liu et al. Scientific Reports
- Discovery of a Locally and Orally Active CXCL12 Neutraligand (LIT-927) with Anti-inflammatory Effect in a Murine Model of Allergic Airway Hypereosinophilia
- (2018) Pierre Regenass et al. JOURNAL OF MEDICINAL CHEMISTRY
- Role of CXCR7 as a Common Predictor for Prognosis in Solid Tumors: a Meta-Analysis
- (2018) Qitai Zhao et al. Journal of Cancer
- Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives
- (2018) Marc Humbert et al. EUROPEAN RESPIRATORY JOURNAL
- Haemodynamic definitions and updated clinical classification of pulmonary hypertension
- (2018) Gérald Simonneau et al. EUROPEAN RESPIRATORY JOURNAL
- Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
- (2017) Athénaïs Boucly et al. EUROPEAN RESPIRATORY JOURNAL
- TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension
- (2017) Rahul Kumar et al. Nature Communications
- Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension
- (2016) Christophe Guignabert et al. JOURNAL OF CLINICAL INVESTIGATION
- Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex
- (2015) Morane Le Hiress et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Leptin signalling system as a target for pulmonary arterial hypertension therapy
- (2015) Alice Huertas et al. EUROPEAN RESPIRATORY JOURNAL
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
- (2015) Nazzareno Galiè et al. EUROPEAN RESPIRATORY JOURNAL
- Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension
- (2015) Takahiro Hashimoto-Kataoka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of CXCR4 and CXCR7 for reduction of cell proliferation and invasion in human endometrial cancer
- (2015) Ping Long et al. TUMOR BIOLOGY
- Elevated Plasma CXCL12α Is Associated with a Poorer Prognosis in Pulmonary Arterial Hypertension
- (2015) Brian N. McCullagh et al. PLoS One
- Immune Dysregulation and Endothelial Dysfunction in Pulmonary Arterial Hypertension
- (2014) Alice Huertas et al. CIRCULATION
- Increased Pericyte Coverage Mediated by Endothelial-Derived Fibroblast Growth Factor-2 and Interleukin-6 Is a Source of Smooth Muscle–Like Cells in Pulmonary Hypertension
- (2014) Nicolas Ricard et al. CIRCULATION
- Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension
- (2014) Marlene Rabinovitch et al. CIRCULATION RESEARCH
- Increased levels of plasma CXC-Chemokine Ligand 10, 12 and 16 are associated with right ventricular function in patients with idiopathic pulmonary arterial hypertension
- (2014) Tao Yang et al. HEART & LUNG
- CXCR4 Inhibition Ameliorates Severe Obliterative Pulmonary Hypertension and Accumulation of C-Kit+ Cells in Rats
- (2014) Daniela Farkas et al. PLoS One
- An Antedrug of the CXCL12 Neutraligand Blocks Experimental Allergic Asthma without Systemic Effect in Mice
- (2013) François Daubeuf et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Blocking Macrophage Leukotriene B4 Prevents Endothelial Injury and Reverses Pulmonary Hypertension
- (2013) W. Tian et al. Science Translational Medicine
- A Critical Role for p130Casin the Progression of Pulmonary Hypertension in Humans and Rodents
- (2012) Ly Tu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Role of chemokine receptor CXCR7 in bladder cancer progression
- (2012) Mingang Hao et al. BIOCHEMICAL PHARMACOLOGY
- Antagonism of CXCR7 attenuates chronic hypoxia–induced pulmonary hypertension
- (2012) Ecaterina Sartina et al. PEDIATRIC RESEARCH
- C-Kit–Positive Cells Accumulate in Remodeled Vessels of Idiopathic Pulmonary Arterial Hypertension
- (2011) David Montani et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities
- (2011) S. Farha et al. BLOOD
- A role for the CXCL12 receptor, CXCR7, in the pathogenesis of human pulmonary vascular disease
- (2011) Christine M. Costello et al. EUROPEAN RESPIRATORY JOURNAL
- Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells
- (2011) A Dar et al. LEUKEMIA
- Prodrugs of a CXC Chemokine-12 (CXCL12) Neutraligand Prevent Inflammatory Reactions in an Asthma Model in Vivo
- (2011) Vincent Gasparik et al. ACS Medicinal Chemistry Letters
- Autocrine Fibroblast Growth Factor-2 Signaling Contributes to Altered Endothelial Phenotype in Pulmonary Hypertension
- (2010) Ly Tu et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression
- (2010) L. Sanchez-Martin et al. BLOOD
- Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension
- (2010) N. Gambaryan et al. EUROPEAN RESPIRATORY JOURNAL
- The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil)
- (2009) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- Inhibition of the SDF-1/CXCR4 Axis Attenuates Neonatal Hypoxia-Induced Pulmonary Hypertension
- (2009) Karen C. Young et al. CIRCULATION RESEARCH
- Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells
- (2009) S. K. Martin et al. HAEMATOLOGICA
- c/EBPβ Is a Major Regulatory Element Driving Transcriptional Activation of the CXCL12 Promoter
- (2009) E. Calonge et al. JOURNAL OF MOLECULAR BIOLOGY
- Early postnatal lethality and cardiovascular defects in CXCR7-deficient mice
- (2008) Han Gerrits et al. GENESIS
- Small Neutralizing Molecules to Inhibit Actions of the Chemokine CXCL12
- (2008) Muriel Hachet-Haas et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis
- (2008) Meizhang Li et al. SEMINARS IN CANCER BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started